Concord Hospital, Neurosciences Department

Concord, New South Wales 02139

0 studies enrolling now · 2 studies all time

What they study most

MSA, Parkinson's Disease (PD), Pure Autonomic Failure (PAF), Symptomatic Neurogenic Orthostatic Hypotension

Studies at this site

• Phase 3 Clinical Effect Durability of TD-9855 for Treating Symptomatic nOH in Subjects With Primary Autonomic Failure — Stopped early
• Phase 3 Open-Label Extension Study of TD-9855 for Treating Symptomatic nOH in Subjects With Primary Autonomic Failure — Stopped early